医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

KILL CORRECTING and REPLACING Chinese Enterprise By-Health Launches the First Personalized Customized Vitamin Concept Product, Leading the Industrialization of Precision Nutrition

2022年01月25日 AM11:20
このエントリーをはてなブックマークに追加


 

By-Health requests that their press release NewsItemId: 20211221005821 issued December 29, 2021 be killed.

The release was issued without third-party approval.

A replacement release will not be issued.

CONTACT

William feng

fengyl2@by-health.com

同じカテゴリーの記事 

  • ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial
  • PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA
  • AriBio 获得欧洲药品管理局对AR1001治疗阿尔茨海默病3期临床试验(POLARIS-AD)的授权
  • AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)
  • ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続